Cited by 1,063Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Open access

Vilar, Eduardo, Gruber, Stephen B.·2010·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2009.237PMC PMC3427139

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2009.237

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876

Show all 100 references

Sorted by citations

Items 301–400 of 1,000

Idiopathic Infertility as a Feature of Genome Instability
Puzuka, A., Alkšere, B., Gailīte, L., & Ērenpreiss, J. (2021) · Life · doi:10.3390/life11070628 · Cited by 27
Sensitive detection of microsatellite instability in tissues and liquid biopsies: Recent developments and updates
Yu, F., Makrigiorgos, A., Leong, K. W., & Makrigiorgos, G. M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.037 · Cited by 27
Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions
Morgan, C. C., Shakya, K., Webb, A. E., Walsh, T., Lynch, M. J., Loscher, C. E., Ruskin, H. J., & O’Connell, M. J. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-114 · Cited by 27
A high lymph node yield in colon cancer is associated with age, tumour stage, tumour sub-site and priority of surgery. Results from a prospective national cohort study
On behalf of the Danish Colorectal Cancer Group, Lykke, J., Jess, P., & Roikjær, O. (2016) · International Journal of Colorectal Disease · doi:10.1007/s00384-016-2599-1 · Cited by 27
Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer
Desai, N., Sajed, D. P., Arora, K. S., Solovyov, A., Rajurkar, M., Bledsoe, J. R., Sil, S., Amri, R., Tai, E. C., Mackenzie, O., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91078 · Cited by 27
CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib
Li, H., Feng, H., Zhang, T., Wu, J., Shen, X., Xu, S., Xu, L., Wang, S., Zhang, Y., Jia, W., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01971-7 · Cited by 26
Systematic review and meta-analysis of deep learning for MSI-H in colorectal cancer whole slide images
Li, H., Qin, J., Li, Z., Ouyang, R., Chen, Z., Huang, S., Qin, S., & Huang, Q. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01848-z · Cited by 28
Genomic and Epigenetic Instability in Colorectal Cancer
Safaei, A., Sobhi, S., Rezaei–Tavirani, M., & Zali, M. R. (2013) · Iranian Journal of Cancer Prevention · Cited by 26
Role of Next-Generation Sequencing Technologies in Personalized Medicine
Morganti, S., Tarantino, P., Ferraro, E., D’Amico, P., Viale, G., Trapani, D., Duso, B. A., & Curigliano, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3_8 · Cited by 30
Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC)
Pang, S.-W., Awi, N. J., Armon, S., Lim, W. W.-D., Low, J. S.-H., Peh, K.-B., Peh, S., & Teow, S. (2019) · Diagnostics · doi:10.3390/diagnostics10010009 · Cited by 28
Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression
Pötzsch, M., Berg, E., Hummel, M., Stein, U., von Winterfeld, M., Jöhrens, K., Rau, B., Daum, S., & Treese, C. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1824632 · Cited by 26
Targeted and immunotherapy in the era of personalised gastric cancer treatment
Catanese, S., & Lordick, F. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101738 · Cited by 26
Computed Tomography-Based Radiomics Model to Preoperatively Predict Microsatellite Instability Status in Colorectal Cancer: A Multicenter Study
Li, Z., Zhong, Q., Zhang, L., Wang, M., Xiao, W., Cui, F., Yu, F., Huang, C., & Feng, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.666786 · Cited by 26
Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers
Chang, L., Chang, M., Chang, H. M., & Chang, F. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9991-0 · Cited by 30
Treating Immunologically Cold Tumors by Precise Cancer Photoimmunotherapy with an Extendable Nanoplatform
Yu, W., Sun, J., Liu, F., Yu, S., Hu, J., Zhao, Y., Wang, X., & Liu, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09469 · Cited by 26
PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers
Hou, Y., Nitta, H., Parwani, A. V., & Li, Z. (2019) · Human Pathology · doi:10.1016/j.humpath.2018.12.007 · Cited by 25
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
van den Ende, T., ter Veer, E., Mali, R. M. A., Henegouwen, M. I. V. B., Hulshof, M. C. C. M., van Oijen, M. G. H., & van Laarhoven, H. W. M. (2019) · Cancers · doi:10.3390/cancers11040530 · Cited by 25
Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study
Yuval, J. B., Lee, J., Wu, F. H., Thompson, H. M., Verheij, F. S., Gupta, H. V., Irie, T., Scarpa, J. R., McCormick, P. J., Smith, J. J., et al. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.04.024 · Cited by 25
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology
Grypari, I. M., Tzelepi, V., & Gyftopoulos, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411418 · Cited by 26
EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix
Dimmler, A. W., Geddert, H., & Faller, G. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.01.002 · Cited by 25
BRCAand Beyond: Comprehensive Image-rich Review of Hereditary Breast and Gynecologic Cancer Syndromes
Chung, S. H., Woldenberg, N., Roth, A. R., Masamed, R., Conlon, W., Cohen, J. G., Joines, M. M., & Patel, M. K. (2020) · Radiographics · doi:10.1148/rg.2020190084 · Cited by 25
Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer
Nakamura, Y., Shida, D., Boku, N., Yoshida, T., Tanabe, T., Takamizawa, Y., Takashima, A., & Kanemitsu, Y. (2021) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002059 · Cited by 24
Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer
Tomasini, P. P., Guecheva, T. N., Leguisamo, N. M., Péricart, S., Brunac, A., Hoffmann, J., & Saffi, J. (2021) · Cancers · doi:10.3390/cancers13133130 · Cited by 25
Molecular testing for colorectal cancer: Clinical applications
Имянитов, Е. Н., & Kuligina, E. S. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1288 · Cited by 26
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Zhao, X., Wang, Y., Jiang, X., Mo, B., Wang, C., Tang, M., Rong, Y., Zhang, G., Hu, M., & Cai, H. (2023) · BMC Cancer · doi:10.1186/s12885-023-10564-4 · Cited by 24
Genomic Characteristics and Prognosis of Lung Cancer Patients with MSI-H: A Cohort Study
Tian, J., Wang, H., Lu, C., Liu, L., Zhang, X., Xie, Y., Li, R., Lv, X., Fu, D., Zhang, L., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2023.107255 · Cited by 24
Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review
Yang, J., Huang, J., Han, D., & Ma, X. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549231220320 · Cited by 25
Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma
Salahshourifar, I., Vincent–Chong, V. K., Chang, H., Ser, H., Ramanathan, A., Kallarakkal, T. G., Rahman, Z. A. A., Ismail, S. M., Prepageran, N., Mustafa, W. M. W., et al. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1467-7 · Cited by 24
Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer
Liu, D. (2016) · FEBS Journal · doi:10.1111/febs.13798 · Cited by 24
Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94
Caccuri, F., Sommariva, M., Marsico, S., Giordano, F., Zani, A., Giacomini, A., Fraefel, C., Balsari, A., & Caruso, A. (2019) · Cancers · doi:10.3390/cancers11071006 · Cited by 24
Predictive models for immune checkpoint inhibitor response in cancer: A review of current approaches and future directions
Oisakede, E. O., Akinro, O., Bello, O. J., Analikwu, C. C., Egbon, E., & Olawade, D. B. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104980 · Cited by 23
The Clinicopathological Features and Prognosis of Tumor MSI in East Asian Colorectal Cancer Patients Using NCI Panel
Zheng, J., Huang, B., Nie, X., Zhu, Y., Han, N., & Li, Y. (2018) · Future Oncology · doi:10.2217/fon-2017-0662 · Cited by 23
Chemoproteogenomic stratification of the missense variant cysteinome
Desai, H. S., Andrews, K. H., Bergersen, K. V., Ofori, S., Yu, F., Shikwana, F., Arbing, M. A., Boatner, L. M., Villanueva, M., Ung, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53520-x · Cited by 24
LINE-1-Derived Poly(A) Microsatellites Undergo Rapid Shortening and Create Somatic and Germline Mosaicism in Mice
Grandi, F. C., Rosser, J. M., & An, W. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss251 · Cited by 23
Cancerous stem cells: deviant stem cells with cancer-causing misbehavior
Chandler, J. M., & Lagasse, E. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt13 · Cited by 25
Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer
Vilar, E., Mork, M. E., Cuddy, A., Borràs, E., Bannon, S. A., Taggart, M. W., Ying, B., Broaddus, R. R., Luthra, R., Rodrı́guez-Bigas, M. A., et al. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.10.002 · Cited by 23
Self-citation
Biomarker-driven and molecular targeted therapies for colorectal cancers
Schirripa, M., Cohen, S. A., Battaglin, F., & Lenz, H. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.06.003 · Cited by 25
MIRMMR: binary classification of microsatellite instability using methylation and mutations
Foltz, S. M., Liang, W.-W., Xie, M., & Ding, L. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx507 · Cited by 23
Role of specialized DNA polymerases in the limitation of replicative stress and DNA damage transmission
Bournique, E., Dall’Osto, M., Hoffmann, J., & Bergoglio, V. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.08.002 · Cited by 26
Recent advances in upper tract urothelial carcinomas: From bench to clinics
Shao, I., Chang, Y., & Pang, S. (2018) · International Journal of Urology · doi:10.1111/iju.13826 · Cited by 23
Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer
Jebelli, A., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Mokhtarzadeh, A., & Tayebi, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21735 · Cited by 23
Colorectal Cancer in Octogenarian and Nonagenarian Patients: Clinicopathological Features and Survivals
Lee, S. M., & Shin, J. S. (2020) · Annals of Coloproctology · doi:10.3393/ac.2020.01.19.2 · Cited by 23
Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
Ribeirinho-Soares, S., Pádua, D., Amaral, A. L., Valentini, E., Azevedo, D., Marques, C., Barros, R., Macedo, F., Mesquita, P., & Almeida, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08070-6 · Cited by 23
Genetic unraveling of colorectal cancer
Rasool, S., Rasool, V., Naqvi, T., Ganai, B. A., & Shah, B. A. (2014) · Tumor Biology · doi:10.1007/s13277-014-1713-7 · Cited by 25
Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers
Weng, J., Ju, F., Lyu, Z., Fan, N., Smit, D. J., Xu, W., Wu, X., Becker, P., Xu, Y., Schweiger, M. R., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03567-5 · Cited by 26
Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
Zhao, L., Luo, B., Wang, L., Chen, W., Jiang, M., & Zhang, N. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-1646 · Cited by 22
Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
Chauvin, A., Bergeron, D., Vencic, J., Lévesque, D., Paquette, B., Scott, M. S., & Boisvert, F. (2022) · BMC Cancer · doi:10.1186/s12885-022-09417-3 · Cited by 23
Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
Pei, F., Wu, J., Zhao, Y., He, W., Yao, Q., Huang, M., & Huang, J. C. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.11.004 · Cited by 22
Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers
Park, Y., Nam, S. K., Seo, S. H., Park, K. U., Oh, H. J., Park, Y. S., Suh, Y., Ahn, S.-H., Park, D. J., Kim, H., et al. (2023) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2023.23.e5 · Cited by 22
Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome
Bolívar, A. M., Düzağaç, F., Sinha, K. M., & Vilar, E. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101204 · Cited by 22
Self-citation
Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients
Chang, Y. C., Chang, J., Liu, T., Lin, C., Yang, S.-F., Ho, C., Chen, W. T., & Chang, Y.-S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2314 · Cited by 22
Biomarker correlation network in colorectal carcinoma by tumor anatomic location
Nishihara, R., Glass, K., Mima, K., Hamada, T., Nowak, J. A., Qian, Z. R., Kraft, P. L., Giovannucci, E. L., Fuchs, C. S., Chan, A. T., et al. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1718-5 · Cited by 24
Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
Baraniskin, A., Laethem, J. V., Wyrwicz, L. S., Güller, U., Wasan, H. S., Matysiak‐Budnik, T., Gruenberger, T., Ducreux, M. P., Carneiro, F., Cutsem, E. V., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.021 · Cited by 23
Colorectal cancer spheroid biobanks: multi-level approaches to drug sensitivity studies
Angelis, M. L. D., Bruselles, A., Francescangeli, F., Pucilli, F., Vitale, S., Zeuner, A., Tartaglia, M., & Baiocchi, M. (2018) · Cell Biology and Toxicology · doi:10.1007/s10565-018-9423-3 · Cited by 22
Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency
Sehested, A. M., Meade, J. C., Scheie, D., Østrup, O., Bertelsen, B., Misiakou, M. A., Sarosiek, T., Kessler, E., Melchior, L. C., Munch‐Petersen, H. F., et al. (2021) · Human Mutation · doi:10.1002/humu.24299 · Cited by 23
DNA Mismatch Repair System: Repercussions in Cellular Homeostasis and Relationship with Aging
Conde-Pérezprina, J. C., León-Galván, M. Á., & Königsberg, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/728430 · Cited by 22
153P Determinants of tumour-immune evolutionary trajectory in colorectal cancer
Lakatos, E., Gunasri, V., Zapata, L., Househam, J., Heide, T., Trahearn, N., Swinyard, O., Cisneros, L. H., Lynn, C., Mossner, M., et al. (2024) · Nature Genetics · doi:10.1016/j.annonc.2024.05.163 · Cited by 22
Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer
Liu, Y., Liu, Z., Hu, Y., Ling, Y., Qing, S., Liu, Y., Zhan, Y., Shen, Z., Fang, Y., & Deng, H. (2025) · Nature Communications · doi:10.1038/s41467-025-60958-0 · Cited by 22
Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma
Kaur, S., Lotsari, J. E., Al‐Sohaily, S., Warusavitarne, J. H., Kohonen‐Corish, M. R. J., & Peltomäki, P. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0059-3 · Cited by 21
Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors
Clarke, S. J., Karapetis, C. S., Gibbs, P., Pavlakis, N., Desai, J., Michael, M., Tebbutt, N. C., Price, T. J., & Tabernero, J. M. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.06.001 · Cited by 21
Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
Liu, J., Wang, Y., Yin, J., Yang, Y. T., Geng, R., Zhong, Z., Ni, S., Liu, W., Du, M., Yu, H., et al. (2022) · Journal of Oncology · doi:10.1155/2022/3477148 · Cited by 21
The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis
Otani, R., Takigawa, H., Yuge, R., Shimizu, D., Ariyoshi, M., Miyamoto, R., Kadota, H., Hiyama, Y., Hayashi, R., Urabe, Y., et al. (2023) · Cancers · doi:10.3390/cancers15051383 · Cited by 22
Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC
Chen, J., Yan, Q., Sun, J., Wang, Q., Tao, Y., Xiao, D., & Xie, B. (2023) · Journal of Cancer · doi:10.7150/jca.81675 · Cited by 21
Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
Sharma, S., Singh, N., Turk, A. A., Wan, I., Guttikonda, A., Dong, J. L., Zhang, X., & Opyrchal, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i13.1815 · Cited by 22
Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids
Yang, Q., Laknaur, A., Elam, L., Ismail, N., Gavrilova-Jordan, L. P., Lue, J., Diamond, M. P., & Al-Hendy, A. A. (2016) · Reproductive Sciences · doi:10.1177/1933719116638186 · Cited by 21
Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study
Jang, M., Kwon, Y., Kim, H., Kim, H., Min, B. S., Park, Y., Kim, T. I., Hong, S. P., & Kim, W. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-5127-6 · Cited by 21
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center
Quaas, A., Rehkämper, J., Rueschoff, J., Pamuk, A., Zander, T., Hillmer, A. M., Siemanowski, J., Wittig, J., Buettner, R., Plum, P. S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.569475 · Cited by 21
Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions
Moon, C., Gordon, M., Moon, D., & Reynolds, T. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312864 · Cited by 21
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
Mazzeschi, M., Sgarzi, M., Romaniello, D., Gelfo, V., Cavallo, C., Ambrosi, F., Morselli, A., Miano, C., Laprovitera, N., Girone, C., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02309-1 · Cited by 21
KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study
Chen, S., Su, X., & Mo, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.812815 · Cited by 21
Can MRI help assess aggressiveness of endometrial cancer?
Ahmed, M. E., Al-Khafaji, J. F., Class, C. A., Wei, W., Ramalingam, P., Wakkaa, H., Soliman, P. T., Frumovitz, M., Iyer, R. B., & Bhosale, P. (2018) · Clinical Radiology · doi:10.1016/j.crad.2018.05.002 · Cited by 20
Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study
Nakayama, Y., Iijima, T., Inokuchi, T., Kojika, E., Takao, M., Takao, A., Koizumi, K., Horiguchi, S., Hishima, T., & Yamaguchi, T. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01968-y · Cited by 20
OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types
Li, X., Hou, L., Zhang, L., Zhang, L., Wang, D., Wang, Z., Wen, M., & Yang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.815480 · Cited by 20
The oncogenic role of tubulin alpha-1c chain in human tumours
Hu, X., Zhu, H., Chen, B., He, X., Shen, Y., Zhang, X., Xu, Y., & Xu, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09595-0 · Cited by 20
Chemical Tools for the Study of DNA Repair
Jun, Y. W., & Kool, E. T. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00608 · Cited by 20
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Karapetis, C. S., & Patel, G. S. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35025 · Cited by 20
Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography
Mokarram, P., Rismanchi, M., Naeeni, M. A., Samiee, S. M., Paryan, M., Alipour, A., Honardar, Z., Kavousipour, S., Naghibalhossaini, F., Mostafavi‐Pour, Z., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3138-1 · Cited by 20
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
Malesci, A., Basso, G., Bianchi, P. P., Fini, L., Grizzi, F., Celesti, G., Caro, G. D., Delconte, G., Dattola, F., Repici, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.827 · Cited by 20
Prevalence estimation of microsatellite instability in colorectal cancers using tissue microarray based methods – A tertiary care center experience
Roy, P., Nayak, S., Arora, N., Arun, I., Roy, M. K., Banerjee, S., Mallick, I., & Mallath, M. K. (2018) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_430_17 · Cited by 20
Chiral DNA sequences as commutable controls for clinical genomics
Deveson, I. W., Madala, B. S., Blackburn, J., Barker, C., Wong, T., Barton, K., Smith, M. A., Watkins, D. N., & Mercer, T. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09272-0 · Cited by 20
A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer
Zhu, W., Feng, D., Shi, X., Li, D., Wei, Q., & Yang, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1042118 · Cited by 20
TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity
Niu, Y., Ding, C., Wang, Q., Yin, J., Li, L., Liu, W., Wang, X., & Huang, L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03513-5 · Cited by 23
Mismatch repair system deficiency is associated with chemoradiotherapy resistance in locally advanced rectal adenocarcinoma patients
Ni, K., Zhan, Y., Liu, Z., Zhao, X., Wang, W. “., Wang, G., Zhang, Z., Li, G., Zhang, X., & Zhang, C. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26771 · Cited by 19
CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer
Lu, K.-Q., Li, Z., Zhang, Q., Yin, Q., Zhang, Y., Ni, W., Jiang, L.-Z., He, W., & Wang, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-56831-7 · Cited by 19
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review
Ashouri, K., Wong, A., Mittal, P., Torres‐Gonzalez, L., Lo, J. H., Soni, S., Algaze, S. D., Khoukaz, T., Zhang, W., Yang, Y., et al. (2024) · Cancers · doi:10.3390/cancers16162796 · Cited by 20
Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer
Wenger, R. H., Fuady, J. H., Bordoli, M. R., Abreu‐Rodríguez, I., Kristiansen, G., Hoogewijs, D., & Stiehl, D. P. (2014) · Hypoxia · doi:10.2147/hp.s54404 · Cited by 19
GUCY2C ligand replacement to prevent colorectal cancer
Blomain, E. S., Pattison, A. M., & Waldman, S. A. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1178429 · Cited by 19
NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy
Chang, S., Kuo, C.-C., Wu, C., Hsiao, C., Hu, J., Hsu, C., Chou, Y., Shih, Y., & Lin, Y. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22529 · Cited by 19
ecTMB: a robust method to estimate and classify tumor mutational burden
Yao, L., Fu, Y., Mohiyuddin, M., & Lam, H. Y. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-61575-1 · Cited by 19
NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR
Yu, F., Leong, K. W., Makrigiorgos, A., Adalsteinsson, V. A., Ladas, I., Ng, K., Mamon, H. J., & Makrigiorgos, G. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1175 · Cited by 19
Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers
Farmanbar, A., Firouzi, S., KNELLER, R. W., & Khiabanian, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03259-0 · Cited by 19
Identification of dirty necrosis in colorectal carcinoma based on multiphoton microscopy
Li, L., Jiang, W., Yang, Y., Chen, Z., Feng, C., Li, H., Guan, G., & Chen, J. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.6.066008 · Cited by 19
Expression of FOXP1 and Colorectal Cancer Prognosis
Smedt, L. D., Palmans, S., Govaere, O., Moisse, M., Boeckx, B., Hertogh, G. D., Prenen, H., Cutsem, E. V., Tejpar, S., Tousseyn, T., et al. (2015) · Laboratory Medicine · doi:10.1309/lm7ihv2nji1phmxc · Cited by 19
Establishing a Biological Profile for Interval Colorectal Cancers
Cisyk, A. L., Singh, H., & McManus, K. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3210-7 · Cited by 19
NLRP3 activation promotes cGAS/STING signaling and antitumor immunity by colorectal cancer cells
Mowat, C., Schiller, D., & Baker, K. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04088-y · Cited by 18
Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
Li, J., Guo, Y., Liu, J., Guo, F., Du, L., Yang, Y. P., Li, X., & Ma, Y. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007420 · Cited by 18
Targeting the PI3K Signalling as a Therapeutic Strategy in Colorectal Cancer
Fernandes, M. S., Sanches, J., & Seruca, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-02771-1_4 · Cited by 18
Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis
Zhang, C., Ding, H., Sun, S., Luan, Z., Liu, G., & Li, Z. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-487 · Cited by 18
The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality
Tarantino, P., Mazzarella, L., Marra, A., Trapani, D., & Curigliano, G. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102169 · Cited by 18
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
Pekarek, L., Fraile‐Μartinez, O., Montero, C. G., Sáez, M. A., Barquero-Pozanco, I., del Hierro-Marlasca, L., Castro-Martinez, P. D., Romero-Bazán, A., Álvarez-Mon, M. Á., Monserrat, J., et al. (2022) · Cancers · doi:10.3390/cancers14081866 · Cited by 18

Authors: Vilar, E., & Gruber, S. B.
Affiliations: University of Michigan (US)
Corresponding author: Gruber, Stephen B.
ORCID: Vilar, Eduardo
Gruber, Stephen B.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2010-02-09
Volume: 7
Issue: 3
Pages: 153-162
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/nrclinonc.2009.237
PMC: PMC3427139
OpenAlex: W2050658928
Cited by: 1,063
References: 100
Citations by year: 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
FWCI: 4.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
MeSH terms: DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks